Role of ribosomal protein mutations in tumor development

KM Goudarzi, MS LINDSTRöM - … journal of oncology, 2016 - spandidos-publications.com
Ribosomes are cellular machines essential for protein synthesis. The biogenesis of
ribosomes is a highly complex and energy consuming process that initiates in the nucleolus …

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications

W Wang, S Nag, X Zhang, MH Wang… - Medicinal research …, 2015 - Wiley Online Library
Ribosomes are essential components of the protein synthesis machinery. The process of
ribosome biogenesis is well organized and tightly regulated. Recent studies have shown …

AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity

G He, YW Zhang, JH Lee, SX Zeng… - … and cellular biology, 2014 - Taylor & Francis
AMP-activated protein kinase (AMPK) has been shown to activate p53 in response to
metabolic stress. However, the underlying mechanisms remain unclear. Here we show that …

[HTML][HTML] p53-dependent and-independent nucleolar stress responses

K Holmberg Olausson, M Nistér, MS Lindström - Cells, 2012 - mdpi.com
The nucleolus has emerged as a cellular stress sensor and key regulator of p53-dependent
and-independent stress responses. A variety of abnormal metabolic conditions, cytotoxic …

MDM2's social network

R Fåhraeus, V Olivares-Illana - Oncogene, 2014 - nature.com
MDM2 is considered a hub protein due to its capacity to interact with a large number of
different partners of which p53 is most well described. MDM2 is an E3 ubiquitin ligase, and …

Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation

J Zheng, Y Lang, Q Zhang, D Cui, H Sun… - Genes & …, 2015 - genesdev.cshlp.org
The central region of MDM2 is critical for p53 activation and tumor suppression. Upon
ribosomal stress, this region is bound by ribosomal proteins, particularly ribosomal protein …

Targeting p53-MDM2-MDMX loop for cancer therapy

Q Zhang, SX Zeng, H Lu - Mutant p53 and MDM2 in Cancer, 2014 - Springer
The tumor suppressor p53 plays a central role in anti-tumorigenesis and cancer therapy. It
has been described as “the guardian of the genome”, because it is essential for conserving …

Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex

JM Liao, X Zhou, A Gatignol, H Lu - Oncogene, 2014 - nature.com
Oncogene MYC is highly expressed in many human cancers and functions as a global
regulator of ribosome biogenesis. Previously, we reported that ribosomal protein (RP) L11 …

Scission of the p53-MDM2 loop by ribosomal proteins

X Zhou, JM Liao, WJ Liao, H Lu - Genes & cancer, 2012 - journals.sagepub.com
The oncoprotein MDM2 is both the transcriptional target and the predominant antagonist of
the tumor suppressor p53. MDM2 inhibits the functions of p53 via a negative feedback loop …

A single synonymous mutation determines the phosphorylation and stability of the nascent protein

K Karakostis, S Vadivel Gnanasundram… - Journal of molecular …, 2019 - academic.oup.com
Abstract p53 is an intrinsically disordered protein with a large number of post-translational
modifications and interacting partners. The hierarchical order and subcellular location of …